2009
DOI: 10.1248/bpb.32.1231
|View full text |Cite
|
Sign up to set email alerts
|

Suppressive Effect of Imipramine on Vincristine-Induced Mechanical Allodynia in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
7
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 35 publications
6
7
0
Order By: Relevance
“…As demonstrated earlier by previous studies, in the present study, vincristine injected rats exhibited CIPN which was evident from significant decrease in nociceptive threshold in thermal, mechanical hyperalgesic, allodynic, and formalin test models [13,34]. Vincristine injected rats also displayed decreased motor nerve conduction velocity, functional (sciatic functional index) loss, oxidative stress and increased TNF-a in sciatic nerve in the present study.…”
Section: Discussionsupporting
confidence: 89%
“…As demonstrated earlier by previous studies, in the present study, vincristine injected rats exhibited CIPN which was evident from significant decrease in nociceptive threshold in thermal, mechanical hyperalgesic, allodynic, and formalin test models [13,34]. Vincristine injected rats also displayed decreased motor nerve conduction velocity, functional (sciatic functional index) loss, oxidative stress and increased TNF-a in sciatic nerve in the present study.…”
Section: Discussionsupporting
confidence: 89%
“…As demonstrated earlier, vincristine-injected mice exhibited CIPN which was evident from significant decrease in nociceptive threshold in hyperalgesic, allodynic, and formalin test models (Hansen et al, 2011;Saika et al, 2009). Vincristine-injected mice also displayed functional (SFI) loss and oxidative stress in sciatic nerve in the present study.…”
Section: Discussionsupporting
confidence: 55%
“…Vincristine, one of the most commonly used chemotherapeutic agents, has been reported to cause severe neurotoxicity in the clinic. In this regard, vincristine has been a useful tool for inducing peripheral neuropathy in rats (Aley, Reichling, & Levine, ; Boyle, Wheeler, & Shenfield, ; Higuera & Luo, ; Wala, Crooks, McIntosh, & Holtman, ) and later in mice (Nakamura, Shimizu, Nishijima, Ueno, & Arakawa, ; Saika et al, ; Uceyler et al, ). Similar to previous studies (Authier et al, ), rats treated with vincristine (75 μg kg −1 day −1 ) lost body weight on day 5 and continued to lose weight throughout the treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, in other rat studies with vincristine administered at 50–150 μg kg −1 , no myelin or axonal damage was observed in the peripheral nerve inside the paw skin (Authier, Gillet, Fialip, Eschalier, & Coudore, ) or in the saphenous nerve (Tanner, Levine, & Topp, ; Topp, Tanner, & Levine, ). Although no pharmacokinetic analyses were performed in this study, based on the literature (Authier et al, ; Saika et al, ), vincristine at the doses we used should attain adequate exposure in both species. Taken together, we highly believe the animals in the current study underwent peripheral neuropathy.…”
Section: Discussionmentioning
confidence: 99%